LimePKphase1: Lime Powder Regimen in Healthy Volunteers

Sponsor
Chulalongkorn University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01273025
Collaborator
(none)
15
1
3
5.1

Study Details

Study Description

Brief Summary

The study aims to investigate the pharmacokinetic parameters and its antioxidative effects in Thai healthy men.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Lime powder regime
Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Medicinal Effect of Lime Powder Regimen in HK-2 Cell Exposed to Lithogenic Crystals and Its Citraturic and Antioxidative Responses in Healthy Volunteers
Study Start Date :
Dec 1, 2010
Anticipated Primary Completion Date :
Mar 1, 2011
Anticipated Study Completion Date :
Mar 1, 2011

Outcome Measures

Primary Outcome Measures

  1. The pharmacokinetic parameters of plasma and urine citrate [6 months]

    The pharmacokinetic parameters of plasma and urine citrate incluiding Cmax, Tmax, Half life, AUC, and elimination rate constant

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Thai healthy male or female aged 18-45 years old

  • BMI 18-25 kg/m2

  • Normal medical history, physical examination and vital signs

  • Normal screening laboratories

  • no history of drug allergies

  • Willingness to take part in the study and provide informed consent

Exclusion Criteria:
  • History of GI, liver, kidney, allergic disease or any other disease that may interfere with the bioavailability of lime powder regimen

  • History of alcohol or drug abuse

  • Heavy smoking

  • Receive any medication within 14 days prior to the study day

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chula clinical research center Bangkok Thailand 10330

Sponsors and Collaborators

  • Chulalongkorn University

Investigators

  • Principal Investigator: Poonsin Poungpairoj, BSc, Chulalongkorn University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01273025
Other Study ID Numbers:
  • PPK-10-003
First Posted:
Jan 10, 2011
Last Update Posted:
Jan 10, 2011
Last Verified:
Jan 1, 2011
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 10, 2011